Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
6.50    0.02 (0.30%)
Bid:
6.00
Ask:
7.00
Spread: 1.00 (16.667%)
Market Cap: £425.55m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

Notification under AIM Rule Schedule Two (g)

9 Oct 2013 08:48

RNS Number : 0827Q
Allergy Therapeutics PLC
09 October 2013
 



9 October 2013

 

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

Notification under AIM Rule Schedule Two (g)

 

Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, makes the following update announcement under AIM Rule Schedule Two (g) regarding Stephen Smith, a non-executive director of Allergy Therapeutics plc.

 

In addition to being a non-executive director of the Company, Stephen Smith acts as a 'company doctor' working with companies in distressed situations and in some cases the role has required a restructuring through a pre-planned administration/receivership or a planned insolvency to ensure an orderly winding down of the business. In providing these services, Stephen Smith was appointed as a director of the companies listed below in Table 1 which had administrators, receivers or liquidators appointed. These companies were part of the following groups:

 

· Texon International Group where Stephen Smith was appointed a director in 2004 and subsequently there was a restructuring in 2005 through a receivership which created a viable group where he continues to be a director.

 

· Ethel Austin Group where Stephen Smith was appointed a director in 2005. In 2008 lenders sold their secured loans to a company which appointed administrators a few days later.

 

· The Food & Drink Group where Stephen Smith was appointed a director in 2008 and administrators were appointed in 2009 in a pre-planned process to achieve a sale of the profitable parts of the business.

 

· Paramount Restaurants Group where Stephen Smith was appointed a director in 2011 and later that year arranged a restructuring and subsequent pre-planned administration to achieve disposals of the profitable parts of the group.

 

· Ennstone plc where Stephen Smith was appointed a director in 2008 and administrators were appointed in 2009 to complete a restructuring which ensured the viability of the UK and European businesses and protected the US business via a Chapter 11 process.

 

Table 1

 

Company

Comments

ACLM Limited (in administration)

Part of Ethel Austin Group

Bluelodge Limited (in administration)

Part of The Food & Drink Group

Burlington Restaurant Limited (in administration)

Part of The Food & Drink Group

Ennstone plc (in administration)

Holding company

Enterprises Realisations Limited (in administration)

Part of The Food & Drink Group

Ethel Austin Retail Group Limited (in administration)

Part of Ethel Austin Group

Ethel Austin Retail Holdings Limited (in administration)

Part of Ethel Austin Group

Futurestar Limited (in administration)

Part of The Food & Drink Group

Group Realisations Limited (in administration)

Part of The Food & Drink Group

Hartford Operations Limited (in administration)

Part of The Food & Drink Group

J Bar Limited (in administration)

Part of The Food & Drink Group

Montana plc (in administration)

Part of The Food & Drink Group

Newtaste Restaurants Limited (in administration)

Part of The Food & Drink Group

Noteframe Limited (in administration)

Part of Ethel Austin Group

Noxet Administration Services Limited

Part of Texon International group

PWC Realisations Limited (in administration)

Part of The Food & Drink Group

Texon Group Limited

Part of Texon International group

Texon Holdings Ltd (in liquidation)

Part of Texon International group

Texon International Limited

Part of Texon International group

The Food & Drink Group plc (in administration)

Part of The Food & Drink Group

USM (Holdings) Ltd

Part of Texon International group

Vantis Financial Management Limited (in administration)

Part of Vantis group

Vantis plc (in administration)

Part of Vantis group

Caffe Uno Brasseries Limited (in administration)

Part of Paramount Restaurants group

Charlotte Street Restaurants Limited

Part of Paramount Restaurants group

Chez Gerard Restaurants Limited (in administration)

Part of Paramount Restaurants group

Craftbutton Limited (in administration)

Part of Paramount Restaurants group

Groupe Chez Gerard Limited (in administration)

Part of Paramount Restaurants group

Groupe Chez Gerard Restaurants Limited (in administration)

Part of Paramount Restaurants group

Leviathan Limited (in liquidation)

Part of Paramount Restaurants group

Paramount Acquisitions Limited (in liquidation)

Part of Paramount Restaurants group

Paramount Holdings Limited (in administration)

Part of Paramount Restaurants group

Paramount Limited (in administration)

Part of Paramount Restaurants group

Paramount Restaurants Limited (in administration)

Part of Paramount Restaurants group

Smile Restaurants Limited (in liquidation)

Part of Paramount Restaurants group

 

 

-Ends-

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 821

Ian Postlethwaite

Finance Director

Manuel Llobet

Chief Executive Officer

www.allergytherapeutics.com

Peel Hunt LLP

+44 (0) 20 7418 8900

James Steel / Dr. Vijay Barathan

FTI Consulting

+44 (0) 207 831 3113

Simon Conway / Victoria Foster Mitchell

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSDIRLAIIV
Date   Source Headline
5th Sep 202311:24 amRNSForm 8 (DD)
5th Sep 20238:22 amRNSForm 8.5 (EPT/RI)
1st Sep 20238:01 amRNSForm 8.5 (EPT/RI)
31st Aug 20238:25 amRNSForm 8.5 (EPT/RI)
30th Aug 20238:20 amRNSForm 8.5 (EPT/RI)
29th Aug 20238:36 amRNSForm 8.5 (EPT/RI)
25th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
24th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
22nd Aug 20238:28 amRNSForm 8.5 (EPT/RI)
21st Aug 20238:21 amRNSForm 8.5 (EPT/RI)
18th Aug 20238:31 amRNSForm 8.5 (EPT/RI)
17th Aug 20238:40 amRNSForm 8.5 (EPT/RI)
16th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
15th Aug 20238:51 amRNSForm 8.5 (EPT/RI)
14th Aug 20238:53 amRNSForm 8.5 (EPT/RI)
11th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
10th Aug 20238:45 amRNSForm 8.5 (EPT/RI)
10th Aug 20237:00 amRNSTrading update for the year ended 30 June 2023
9th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
8th Aug 20238:03 amRNSForm 8.5 (EPT/RI)
7th Aug 20239:39 amRNSForm 8.5 (EPT/RI)
4th Aug 20238:57 amRNSForm 8.5 (EPT/RI)
3rd Aug 20238:25 amRNSForm 8.5 (EPT/RI)
2nd Aug 20238:48 amRNSForm 8.5 (EPT/RI)
1st Aug 20238:26 amRNSForm 8.5 (EPT/RI)
31st Jul 20232:33 pmRNSResult of General Meeting
31st Jul 20238:28 amRNSForm 8.5 (EPT/RI)
28th Jul 20239:01 amRNSForm 8.5 (EPT/RI)
27th Jul 20238:25 amRNSForm 8.5 (EPT/RI)
26th Jul 20238:35 amRNSForm 8.5 (EPT/RI) - Allergy Therapeutics plc
25th Jul 20239:17 amRNSForm 8.5 (EPT/RI)
24th Jul 20238:15 amRNSForm 8.5 (EPT/RI)
21st Jul 20238:58 amRNSForm 8.5 (EPT/RI)
20th Jul 20238:09 amRNSForm 8.5 (EPT/RI)
19th Jul 20238:59 amRNSForm 8.5 (EPT/RI)
18th Jul 20238:19 amRNSForm 8.5 (EPT/RI)
17th Jul 20238:48 amRNSForm 8.5 (EPT/RI)
14th Jul 20238:36 amRNSForm 8.5 (EPT/RI)
13th Jul 20238:23 amRNSForm 8.5 (EPT/RI)
12th Jul 20238:44 amRNSForm 8.5 (EPT/RI)
11th Jul 20238:15 amRNSForm 8.5 (EPT/RI)
10th Jul 20231:12 pmRNSAppointment of Chief Financial Officer
10th Jul 20238:33 amRNSForm 8.5 (EPT/RI)
7th Jul 20238:28 amRNSForm 8.5 (EPT/RI)
6th Jul 20238:20 amRNSForm 8.5 (EPT/RI)
5th Jul 20238:45 amRNSForm 8.5 (EPT/RI)
4th Jul 20238:35 amRNSForm 8.5 (EPT/RI) - Allergy Therapeutics PLC
3rd Jul 20239:39 amRNSForm 8.5 (EPT/RI)
30th Jun 202312:08 pmRNSForm 8.5 (EPT/RI)
29th Jun 20238:31 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.